DSD Models at Malawi Sentinel Sites (SENTINEL 2-Malawi)
NCT ID: NCT05901727
Last Updated: 2026-01-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
15520 participants
OBSERVATIONAL
2021-06-01
2027-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
AMBIT is a set of data synthesis, data collection, and data analysis activities aimed at generating information for near- and long-term decision making and creating an approach and platform for ongoing evaluation of differentiated models of HIV treatment delivery. The first AMBIT protocol, "Gathering Records to Evaluate Antiretroviral Treatment" (GREAT, Malawi NHRC 2376), collects and analyzes comprehensive patient medical record data, allowing us to assess the effect of DSD models on patients' clinical outcomes and to evaluate uptake of DSD models at scale.
The Sentinel-Malawi study, the second AMBIT protocol, is examining the effect of DSD models on patient and provider satisfaction, service delivery capacity and quality, costs to patients, and other outcomes for which data are not routinely collected in patient-level medical records. The first round of Sentinel-Malawi was conducted in 2021. The investigators are now amending the protocol to allow up to two additional annual rounds of data collection, in 2022-2023. The investigators collected clinic aggregate data, conducted surveys of patients and providers, and observed operations at a selected set of 12 Malawian healthcare facilities and their affiliated DSD models in Round 1. Round 2 and 3 will collect the same types of data at 12 facilities in Malawi and will expand the study's research questions to include differentiated models of HIV testing and linkage to care. Results are expected to inform Malawian policy makers and other local and international stakeholders on the actual implications of DSD models for patients, health system operations, and healthcare budgets.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
DSD Models at Zambia Sentinel Sites (SENTINEL 2)
NCT05902572
DSD Models at South Africa Sentinel Sites
NCT05886530
Optimizing Care Delivery to Support Reengagement in PLWH Returning to HIV Care After Treatment Lapses in Zambia
NCT06803316
Improving HIV Prevention Among Heterosexual Men Seeking STI Services in Malawi
NCT06200545
Promoting Uptake and Retention of Option B+ in Malawi
NCT02005835
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
HIV treatment survey participants
HIV treatment patients eligible to be enrolled in the patient survey
No intervention
Observational data collection only.
Provider survey participants
HIV treatment providers eligible to be enrolled in the provider survey
No intervention
Observational data collection only.
Time and motion observation participants
HIV treatment providers eligible to be enrolled in the time and motion observation study
No intervention
Observational data collection only.
HIV testing survey participants
Individuals presenting for HIV testing eligible to be enrolled in the HIV testing survey
No intervention
Observational data collection only.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention
Observational data collection only.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Directly or indirectly involved in the site's implementation of ART and DSD models
* Employed in current role at the study site for at least six months
* Provides written informed consent to participate
* Direct or indirect service provider at the study site (indirect providers include supervisors, technical advisors, etc.)
* Directly or indirectly involved in the site's implementation of ART and DSD models
* Employed in current role at the study site for at least six months
* Provides written informed consent to participate.
* Living with HIV and on ART for at least six months at the study site
* ≥ 16 years old (16 and older considered adult for research purposes in Malawi)
* Enrolled in a specified model of care (including conventional care) up to the target number of participants for that model and have received at least one medication refill under this model
* Provide written informed consent to participate.
* Undergoing HIV testing at the study site or other testing site within the catchment area
* ≥ 16 years old (16 and older considered adult for research purposes in Malawi)
* Provide written informed consent to participate.
Exclusion Criteria
● None.
* Unable to communicate in any of the languages into which the questionnaire has been translated or that is known to the research assistant
* Not physically, mentally, or emotionally able to participate in the study, in the opinion of the investigators or study staff.
* Unwilling to take the time required to complete the questionnaire on the day of consent.
* Unable to communicate in any of the languages into which the questionnaire has been translated or that is known to the research assistant
* Not physically, mentally, or emotionally able to participate in the study, in the opinion of the investigators or study staff.
* Unwilling to take the time required to complete the questionnaire on the day of consent.
15 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Health Economics and Epidemiology Research Office (HE2RO), University of the Witwatersrand
UNKNOWN
Clinton Health Access Initiative-Malawi
UNKNOWN
Boston University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sydney Rosen, MPA
Role: PRINCIPAL_INVESTIGATOR
Department of Global Health, BU School of Public Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHAI-Malawi
Lilongwe, , Malawi
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Project website
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
21/03267
Identifier Type: OTHER
Identifier Source: secondary_id
H-41345
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.